Skip to main content
Fig. 7 | BMC Medical Genomics

Fig. 7

From: AZU1 (HBP/CAP37) and PRKCG (PKC-gamma) may be candidate genes affecting the severity of acute mountain sickness

Fig. 7

The analysis results of the LLS subgroup are validated by the AMS-C subgroup. (a) AMS-C differences between the NM-AMS-C and MS-AMS-C groups. (b) The difference in AZU1 expression between the two groups. (c) The difference in PRKCG expression between the two groups. (d) ROC curve analysis of AZU1 predicted MS-AMS-C. (e) ROC curve analysis of PRKCG predicted MS-AMS-C. (f) ROC curve analysis of AZU1&PRKCG predicted MS-AMS-C. (g) Correlation of AZU1 with AMS-C. (h) Correlation of PRKCG with AMS-C. (i) AZU1 expression in the blood of patients with varying degrees of AMS. (j) PRKCG expression in the blood of patients with varying degrees of AMS

Back to article page